SAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Monday reported a loss of $49.5 million in its third quarter.
On a per-share basis, the San Carlos, California-based company said it had a loss of 40 cents.
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for a loss of 40 cents per share.
Iovance Biotherapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $20.46, more than doubling in the last 12 months.